Metro Healthcare Indonesia Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Metro Healthcare Indonesia Tbk. trades at Rp428 (market cap 14.23T, 346.3K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,520 (market cap 11.18T, 613K 24h volume). The key difference: Metro Healthcare Indonesia Tbk. is the larger of the two by market cap, and Tempo Scan Pacific Tbk. is more actively traded (613K versus 346.3K). Which is the better fit depends on your goals.
| CARE | TSPC | |
|---|---|---|
Market Cap | 14.23T | 11.18T |
Volume | 346.3K | 613K |
Lot | 3.46K | 6.13K |
Turnover | 147.93M | 1.54B |
Average Price | 427.18 | 2,511.52 |
Value | 147.93M | 1.54B |
Indicative Equilibrium Price | 428 | 2,520 |
Indicative Equilibrium Volume | 10 | 17 |
Trailing returns across standard periods
Latest headlines on both assets
PT Metro Healthcare Indonesia Tbk (the “Company”) was established under the name PT Aruna Anjaya Perkasa, based on Notarial Deed No. 67 dated October 07, 2015 of Humberg Lie, S.H., S.E., M.Kn notary in Jakarta. The Company started its commercial operations in 2016 .
Read more on CARE →PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →